RecruitingNot ApplicableNCT07064395

Bright Light Therapy on Sleep Health in Lung Cancer Patients

Bright Light Therapy to Reduce Sleep Disturbance and Biological Aging in Lung Cancer Patients


Sponsor

Henry Ford Health System

Enrollment

20 participants

Start Date

Jun 9, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this randomized intervention trial is to determine the effect of bright light therapy on sleep disturbance, as well as to investigate the impacts of bright light therapy on biological age measured by clinical biomarkers. The main questions it aims to answer are: * Does bright light therapy improve sleep patterns (i.e., sleep onset latency, sleep disturbance, and sleep efficiency) in lung cancer patients? * Can bright light therapy slow the rate of aging measured by biological age in lung cancer patients? Researchers will compare bright light therapy group to control group to see if bright light works to reduce sleep disturbance and decelerate biological aging. Participants will: * Receive bright light exposure or usual light exposure every day for 4 weeks * Get blood draw at the baseline and at 4 weeks for clinical biomarkers tests * Complete self-reported sleep, fatigue and stress surveys at the baseline and at 4 weeks * Keep a daily sleep log


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study tests bright light therapy — daily exposure to a special lamp that mimics sunlight — to improve sleep in people with lung cancer who have completed primary treatment and suffer from insomnia. **You may be eligible if...** - You are 18 years or older - You have been diagnosed with stage Ib to IIIb primary lung cancer - You finished your main cancer treatment at least 2 months ago (ongoing maintenance or immunotherapy is allowed) - You experience significant sleep problems (score of 8 or more on the Insomnia Severity Index) - You can read, speak, and understand English and are mentally able to consent **You may NOT be eligible if...** - You are pregnant - Your cancer has spread to distant organs (metastatic) - You are on supplemental oxygen - You have seasonal affective disorder, a substance use disorder, or a diagnosed sleep condition being treated (such as sleep apnea or narcolepsy) - You have recently done shift work or crossed more than 3 time zones in the past 2 weeks Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERbright light

Lung cancer patients in the bright light arm will receive 12,000 lux bright light through light visor for 4 weeks.


Locations(1)

Henry Ford Health System

Detroit, Michigan, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07064395


Related Trials